Cargando…

Rituximab Concentration Varies in Patients With Different Lymphoma Subtypes and Correlates With Clinical Outcome

Individual variations in concentrations of rituximab in different B cell non-Hodgkin’s lymphoma subtypes and their relevance to efficacy were still unclear. From 2016 to 2021, a prospective clinical trial was conducted, and 510 samples with 6 uncommon subtypes of B-cell lymphoma were enrolled to exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shu, Wang, Zhao, Chen, Rongxin, Wang, Xueding, Fang, Xiaojie, Chen, Zhuojia, Guan, Shaoxing, Liu, Tao, Lin, Tongyu, Huang, Min, Huang, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832337/ https://www.ncbi.nlm.nih.gov/pubmed/35153779 http://dx.doi.org/10.3389/fphar.2022.788824

Ejemplares similares

Rituximab exposure‐response in triweekly R‐CHOP treatment in DLBCL: A loading dose is recommended to improve clinical outcomes
por: Liu, Shu, et al.
Publicado: (2021)

Rituximab Therapy for Primary Sjögren’s Syndrome
por: Chen, Yi Han, et al.
Publicado: (2021)

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma
por: Patra-Kneuer, Maria, et al.
Publicado: (2023)

Rituximab in patients with membranous nephropathy and kidney insufficiency
por: Guo, Yanhong, et al.
Publicado: (2022)

Integrated bioinformatics analysis uncovers characteristic genes and molecular subtyping system for endometriosis
por: Wang, Zhaowei, et al.
Publicado: (2022)

Correlations among the plasma concentrations of first-line anti-tuberculosis drugs and the physiological parameters influencing concentrations
por: Cheng, Lin, et al.
Publicado: (2023)

A Cost-Effectiveness Analysis: First-Line Avelumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma
por: Lu, Peiyao, et al.
Publicado: (2020)

Excretion and Residual Concentration Correlations of Salbutamol Between Edible Tissues and Living Samples in Pigs and Goats
por: Sun, Lei, et al.
Publicado: (2021)

The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study
por: Galimberti, Sara, et al.
Publicado: (2017)

Cardiovascular adverse events associated with cyclophosphamide, pegylated liposomal doxorubicin, vincristine, and prednisone with or without rituximab ((R)-CDOP) in non-Hodgkin’s lymphoma: A systematic review and meta-analysis
por: Lu, Bin, et al.
Publicado: (2022)

Rituximab Hypersensitivity: From Clinical Presentation to Management
por: Fouda, Ghada E., et al.
Publicado: (2020)

A Cell-Based Metabonomics Approach to Investigate the Varied Influences of Chrysophanol-8-O-β-D-Glucoside With Different Concentrations on L-02 Cells
por: Liu, Meichen, et al.
Publicado: (2019)

Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
por: Li, Xueying, et al.
Publicado: (2019)

Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature
por: Kuang, Zhixing, et al.
Publicado: (2021)

Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome
por: Chen, Yewei, et al.
Publicado: (2021)

Clinical Attributes and Electroencephalogram Analysis of Patients With Varying Alpers’ Syndrome Genotypes
por: Li, Hua, et al.
Publicado: (2021)

Global Pattern of CD8(+) T-Cell Infiltration and Exhaustion in Colorectal Cancer Predicts Cancer Immunotherapy Response
por: Tian, Sun, et al.
Publicado: (2021)

Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis
por: He, Xin, et al.
Publicado: (2014)

Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity
por: Wang, He, et al.
Publicado: (2023)

Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study
por: Ye, Qinghua, et al.
Publicado: (2022)

A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression
por: Zhou, Zijun, et al.
Publicado: (2020)

Efficacy and Safety of Raltegravir-Based Dual Therapy in AIDS Patients: A Meta-Analysis of Randomized Controlled Trials
por: Huang, Yinqiu, et al.
Publicado: (2019)

Rituximab for the treatment of connective tissue disease–associated interstitial lung disease: A systematic review and meta-analysis
por: Xu, Linrui, et al.
Publicado: (2022)

Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal
por: Xiong, Yu, et al.
Publicado: (2023)

Phytohormone Abscisic Acid Improves Spatial Memory and Synaptogenesis Involving NDR1/2 Kinase in Rats
por: Liu, Juanjuan, et al.
Publicado: (2018)

Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma
por: Cai, Qingqing, et al.
Publicado: (2014)

Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients
por: Zhang, Biao, et al.
Publicado: (2023)

Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer
por: Fang, Hanyi, et al.
Publicado: (2021)

Correlation of the Plasma Concentration of Eltrombopag With Efficacy in the Treatment of Refractory Aplastic Anemia: A Single-Centre Study in China
por: Zuo, Wei, et al.
Publicado: (2020)

Prognostic Value of the Modified Systemic Inﬂammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma
por: Huang, He, et al.
Publicado: (2020)

Nucleus-Targeting Phototherapy Nanodrugs for High-Effective Anti-Cancer Treatment
por: Long, Xingyu, et al.
Publicado: (2022)

Factors related to irritable bowel syndrome and differences among subtypes: A cross-sectional study in the UK Biobank
por: Wang, Kexin, et al.
Publicado: (2022)

Artemisinin derivative DHA27 enhances the antibacterial effect of aminoglycosides against Pseudomonas aeruginosa by inhibiting mRNA expression of aminoglycoside-modifying enzymes
por: Wang, Nuoyan, et al.
Publicado: (2022)

Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma
por: Li, Ru, et al.
Publicado: (2022)

Hypokalemia After Rituximab Administration in Steroid-Dependent Nephrotic Syndrome: A Case Report
por: Guzzi, Francesco, et al.
Publicado: (2020)

Intensive Safety Monitoring of Rituximab (Biosimilar Novex(®) and the Innovator) in Pediatric Patients With Complex Diseases
por: Riva, Natalia, et al.
Publicado: (2022)

The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system
por: Wang, Qiaona, et al.
Publicado: (2023)

Establishment and application of a predictive model for gefitinib-induced severe rash based on pharmacometabolomic profiling and polymorphisms of transporters in non-small cell lung cancer
por: Guan, Shaoxing, et al.
Publicado: (2020)

Identification of angiogenesis-related subtypes, the development of prognostic models, and the landscape of tumor microenvironment infiltration in colorectal cancer
por: Zhang, Chen, et al.
Publicado: (2023)

The Role of ASIC1a in Inflammatory Immune Diseases: A Potential Therapeutic Target
por: Wang, Yinghong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8tmj3bs52bom1tnlj1rj93cqrn